Related pages Drug Information Summaries Approval Process for New Cancer Treatments Access to Investigational Drugs: Q & A

This page contains brief information about rituximab and a collection of links to more information from the National Cancer Institute (NCI), the Food and Drug Administration (FDA), and the National Library of Medicine (NLM).

US Brand Name(s):		Rituxan
FDA Approved:		Yes

Rituximab is approved by the Food and Drug Administration (FDA) to be used together with other drugs to treat certain types of non-Hodgkin’s lymphoma. It is also approved to be used together with methotrexate to treat rheumatoid arthritis.

Rituximab is also being studied in the treatment of other types of cancer and other conditions.

FDA Approval for Rituximab - Information from the FDA about the approval of this drug and the clinical trials that led to the approval.

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Clinical Trial Results: Elderly with B-Cell Lymphoma Gain from Rituxumab (07/10/2006) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Rituximab Benefits Younger Lymphoma Patients (05/03/2006) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Rituximab and Recurrent Lymphomas (10/26/2005) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Follicular Lymphoma Treatment Better With Rituximab (05/15/2005) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Rituximab Works in Mantle Cell Lymphoma (06/05/2004) - Important clinical trial results for this drug, background information, and how the trial was done.

MedlinePlus Information on Rituximab - A lay language summary of important information about this drug that may include the following:

• warnings about this drug,
• what this drug is used for and how it is used,
• what you should tell your doctor before using this drug,
• what you should know about this drug before using it,
• other drugs that may interact with this drug, and
• possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This NLM patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Clinical Trials for Rituximab - Check for trials from NCI's PDQ Cancer Clinical Trials Registry now accepting patients.

Back to Top